Arctic Glacier Issues Default Status Report Pursuant to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
131
Arctic Glacier Issues Default Status Report Pursuant to National Policy 12-203

WINNIPEG, Manitoba, July 05, 2018 (GLOBE NEWSWIRE) -- Arctic Glacier Income Fund (CSE:AG.UN) (the “Fund”) is providing a default status report, in accordance with the alternative information guidelines set out in National Policy 12-203 Cease Trade Orders for Continuous Disclosure Defaults (“National Policy 12-203”).

On August 15, 2012, the Fund announced (the “Default Announcement”) that it would not be able to file an interim financial report and interim management's discussion and analysis for the period ended June 30, 2012, together with the related certification of filings under National Instrument 52-109 Certification of Disclosure in Issuers ’ Annual and Interim Filings (collectively, the “Continuous Disclosure Documents”) by August 29, 2012, the deadline prescribed by securities legislation (the “Specified Requirement”).

Except as discussed below, there have been no material changes to the information contained in the Default Announcement or any other changes required to be disclosed under National Policy 12-203.

The Fund still intends to file the Continuous Disclosure Documents as soon as is commercially reasonable, or as required by the Manitoba Court of Queen's Bench pursuant to the Fund's Companies’ Creditors Arrangement Act (the “CCAA”) proceedings. More information about the Arctic Glacier Parties’ CCAA proceeding can be found on the website of its Court-appointed monitor at http://www.alvarezandmarsal.com/arctic-glacie...bsidiaries.

Forward-Looking Statements

Certain statements included herein constitute “forward-looking statements”. All statements, other than statements of historical fact, included in this release that address future activities, events, developments or financial performance are forward-looking statements. These forward-looking statements can be identified by the use of forward-looking words such as “may”, “should”, “will”, “could”, “expect”, “intend”, “plan”, “estimate”, “anticipate”, “believe”, “future” or “continue” or the negative thereof or similar variations. In particular, statements about the Fund's intentions to satisfy the provisions of the alternative information guidelines and file information with the applicable securities regulatory authorities, as well as the expected timetable for satisfying the Specified Requirement, are or involve forward-looking information. These forward-looking statements are based on certain assumptions and analyses made by the Fund and its management, in light of their experiences and their perception of historical trends, current conditions and expected future developments, as well as other factors they believe are appropriate in the circumstances. Investors are cautioned not to put undue reliance on such forward-looking statements, which are not a guarantee of performance and are subject to a number of uncertainties, assumptions and other factors, many of which are outside the control of the Fund, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, among other things, the CCAA process and the Fund's ability to secure sufficient resources to prepare the Continuous Disclosure Documents. Readers are cautioned that the foregoing list is not exhaustive. Such forward-looking statements should, therefore, be construed in light of such factors. If any of these risks or uncertainties were to materialize, or if the factors and assumptions underlying the forward-looking information were to prove incorrect, actual results could vary materially from those that are expressed or implied by the forward-looking information contained herein. All forward-looking statements attributable to the Fund, or persons acting on its behalf, are expressly qualified in their entirety by the cautionary statements set forth above. Readers are cautioned not to place undue reliance on forward-looking statements contained herein, which reflect the analysis of the management of the Fund, as appropriate, only as of the date of this release. For more information regarding these and other risks, readers should consult the Fund’s reports on file with applicable securities regulatory authorities accessible online by going to SEDAR at www.sedar.com or by going to the website of its Court-appointed monitor at http://www.alvarezandmarsal.com/arctic-glacie...bsidiaries . The Fund is under no obligation, and Fund expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.

About the Fund Arctic Glacier Income Fund trust units are listed on the Canadian National Stock Exchange under the trading symbol AG.UN. There are 350.3 million trust units outstanding.

Contact: Hugh Adams Ph: 204-781-4496 Email: hugh@hughadamslaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles

Top 5 Most Recently Viewed Articles

Exploring the Growth of the Sodium Bisulfite Market by 2034

Updated Category News Views 133

Understanding the Growth of the Sodium Bisulfite Market The sodium bisulfite market is experiencing significant momentum as it progresses towards a bright future, with expectations of reaching USD 1,180.7 million by 2034, up from USD 750.3 million in 2024. This growth is driven by an increasing awareness of environmental issues and its versatile applications in various...

Continue Reading
Photocure ASA Reports Impressive Q2 Growth and Outlook

Updated Category News Views 153

Photocure ASA Achieves Record Revenue in Q2 Photocure ASA has shared strong results for the second quarter of the year, showcasing remarkable growth in its Hexvix/Cysview product line. This quarter marked an unprecedented achievement with revenues reaching NOK 135.6 million, reflecting a significant increase compared to NOK 122.4 million from the same period last year....

Continue Reading
Ben & Jerry's Unveils New Flavor Inspired by Noah Kahan

Updated Category News Views 273

Ben & Jerry's Launches Exclusive Flavor with Noah Kahan Ben & Jerry's, the iconic ice cream brand that loves to explore creative flavors, has just introduced an exciting new flavor called Northern Latte-tude. This one-of-a-kind creation is the result of a collaboration with musician Noah Kahan, with the goal of not only delighting fans but also supporting an important...

Continue Reading
Cisco Analyst Coverage Initiation Highlights: Stocks to Watch

Updated Category News Views 141

Latest Analyst Ratings on Notable Stocks In a dynamic market environment, top analysts analyze and provide insights on various companies. Recently, several key analysts have shared significant ratings and price targets for notable stocks, including Cisco Systems, Inc. (NASDAQ: CSCO) and Shopify Inc. (NASDAQ: SHOP). Let's delve into what they have to say. Shopify Inc....

Continue Reading
Nike's Leadership Shakeup: A Bright Future Ahead for the Brand

Updated Category News Views 205

Nike's Steady Outlook Amid Leadership Changes BMO Capital Markets has recently reaffirmed its Outperform rating for Nike Inc. (NYSE:NKE), setting a price target at $92.00 per share. This positive outlook follows the recent appointment of Elliott Hill as President and CEO, a change many investors have eagerly awaited. Hill's return is seen as a hopeful sign for the...

Continue Reading